Regadenoson Injection, Solution
Product Images NDC 76329-3321

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 76329-3321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by International Medication Systems, Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (3321carton)

Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) in a single-dose pre-filled syringe for intravenous use by International Medication Systems, Limited. The label includes administration instructions, storage details, and cautions, highlighting it as a sterile, preservative-free, nonpyrogenic radiopharmaceutical for diagnostic purposes only. The packaging also notes the NDC 76329-3321-0 and emphasizes use with Luer-Lok prefilled syringes.*

FDA Label Image

Structure (Structuralform)

Chemical structure of regadenoson, depicting its molecular framework with characteristic rings and functional groups consistent with the active ingredient regadenoson.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.